October 2, 2012
The Ministry of Health, Labor and Welfare (MHLW) on September 28 granted approval for 16 active pharmaceutical ingredients (APIs)/26 products, including Novartis Pharma’s Seebri Inhalation Capsules 50 μg (glycopyrronium bromide), a treatment for chronic obstructive pulmonary diseases (COPD), and Bayer...read more